Literature DB >> 8042017

Clinical picture of hypolactasia and lactose intolerance.

K Villako1, H Maaroos.   

Abstract

Selective adult-type hypolactasia, the main cause of primary malabsorption of lactose, shows considerable variation in terms of its symptoms, which mainly depend on the amount of milk consumption. The article discusses congenital lactase deficiency and familial lactose intolerance. Links between hypolactasia and non-specific abdominal complaints, coronary heart disease and cataract are presented. The decrease in lactase activity in the brush border of jejunal mucosa, associated with diseases of the mucosa or any other condition which damages the enterocytes, is discussed as a cause of secondary hypolactasia. It is shown that adult-type primary hypolactasia and selective lactose malabsorption represent a major problem in the everyday work of general practitioners, particularly in populations where hypolactasia is common. Therefore, the examination and treatment of non-selected patients with vague abdominal complaints is important in primary health care. As the need for calcium in humans is largely met by the intake of milk, the consumption of milk has to be in amounts that are tolerable for the individual.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042017     DOI: 10.3109/00365529409091743

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  8 in total

1.  Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers.

Authors:  Jan L Madsen; Jan Linnet; Jüri J Rumessen
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Lactose digestion and the evolutionary genetics of lactase persistence.

Authors:  Catherine J E Ingram; Charlotte A Mulcare; Yuval Itan; Mark G Thomas; Dallas M Swallow
Journal:  Hum Genet       Date:  2008-11-26       Impact factor: 4.132

3.  Can lactase persistence genotype be used to reassess the relationship between renal cell carcinoma and milk drinking? Potentials and problems in the application of Mendelian randomization.

Authors:  Nicholas J Timpson; Paul Brennan; Valérie Gaborieau; Lee Moore; David Zaridze; Vsevolod Matveev; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Wong-Ho Chow; Nathaniel Rothman; Paolo Boffetta; Roger M Harbord; George Davey Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

4.  Correlation of G/A -22018 single-nucleotide polymorphism with lactase activity and its usefulness in improving the diagnosis of adult-type hypolactasia among North Indian children.

Authors:  Raja A H Kuchay; Mumtaz Anwar; Babu R Thapa; Akhtar Mahmood; Safrun Mahmood
Journal:  Genes Nutr       Date:  2012-07-05       Impact factor: 5.523

5.  Lactase persistence-related genetic variant: population substructure and health outcomes.

Authors:  George Davey Smith; Debbie A Lawlor; Nic J Timpson; Jamil Baban; Matt Kiessling; Ian N M Day; Shah Ebrahim
Journal:  Eur J Hum Genet       Date:  2008-09-17       Impact factor: 4.246

6.  Lactase non-persistent genotype influences milk consumption and gastrointestinal symptoms in Northern Russians.

Authors:  Yulia Khabarova; Suvi Tornianen; Sari Tuomisto; Irma Järvelä; Pekka Karhunen; Mauri Isokoski; Kari Mattila
Journal:  BMC Gastroenterol       Date:  2011-11-13       Impact factor: 3.067

7.  Prevalence of self-reported stomach symptoms after consuming milk among indigenous Sami and non-Sami in Northern- and Mid-Norway - the SAMINOR study.

Authors:  Ketil Lenert Hansen; Magritt Brustad; Knut Johnsen
Journal:  Int J Circumpolar Health       Date:  2015-02-17       Impact factor: 1.228

8.  Evaluation of breath, plasma, and urinary markers of lactose malabsorption to diagnose lactase non-persistence following lactose or milk ingestion.

Authors:  Aahana Shrestha; Matthew P G Barnett; Jo K Perry; David Cameron-Smith; Amber M Milan
Journal:  BMC Gastroenterol       Date:  2020-06-29       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.